Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
We report our results of autologous stem cell transplantation (SCT) in patients with AML during the last 13 years. Between August 1990 and December 2003, 42 patients with acute myeloid leukemia (AML) received an autologous SCT. Patients were classified as standard risk if first complete remission (C...
Main Authors: | Carlos Martins, João F Lacerda, Fernanda Lourenço, José A Carmo, J M F Lacerda |
---|---|
Format: | Article |
Language: | English |
Published: |
Ordem dos Médicos
2005-10-01
|
Series: | Acta Médica Portuguesa |
Online Access: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1046 |
Similar Items
-
History and Development of Autologous Stem Cell Transplantation for Acute Myeloid Leukemia
by: Norbert Claude Gorin
Published: (2021-07-01) -
Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?
by: Felicetto Ferrara, et al.
Published: (2019-12-01) -
The outcome of Autologous Stem Cell Transplantation in First Complete Remission Acute Myeloid Leukemia Patients- Single Center Study
by: Arash Jalali, et al.
Published: (2011-10-01) -
The outcome of Autologous Stem Cell Transplantation in First Complete Remission Acute Myeloid Leukemia Patients- Single Center Study
by: Ardeshir Ghavamzadeh, et al.
Published: (2011-12-01) -
Outcome of autologous stem cell transplantation in patients with favorable-risk acute myeloid leukemia in first remission
by: Juan Chen, et al.
Published: (2022-10-01)